{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:46:18Z","timestamp":1782139578193,"version":"3.54.5"},"reference-count":73,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T00:00:00Z","timestamp":1473811200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00005-016-0420-z","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T18:52:40Z","timestamp":1473879160000},"page":"189-199","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The Use of Omalizumab in Food Oral Immunotherapy"],"prefix":"10.2478","volume":"65","author":[{"given":"Roxane","family":"Labrosse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Des Roches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9089-4604","authenticated-orcid":false,"given":"Philippe","family":"B\u00e9gin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2016,9,14]]},"reference":[{"key":"420_CR1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/1874226200801010025","volume":"1","author":"G Achatz","year":"2008","unstructured":"Achatz G, Lamers M, Crameri R (2008) Membrane bound IgE\u2014the key receptor to restrict high IgE levels. Open Immunol J 1:25\u201332","journal-title":"Open Immunol J"},{"key":"420_CR2","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2222.2011.03699.x","volume":"41","author":"K Anagnostou","year":"2011","unstructured":"Anagnostou K, Clark A, King Y et al (2011) Efficacy and safety of high-dose peanut oral immunotherapy with factors predicting outcome. Clin Exp Allergy 41:1273\u20131281","journal-title":"Clin Exp Allergy"},{"key":"420_CR3","doi-asserted-by":"crossref","first-page":"7456","DOI":"10.4049\/jimmunol.176.12.7456","volume":"176","author":"AL Andrews","year":"2006","unstructured":"Andrews AL, Holloway JW, Holgate ST et al (2006) IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets. J Immunol 176:7456\u20137461","journal-title":"J Immunol"},{"key":"420_CR4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","volume":"371","author":"LA Beck","year":"2014","unstructured":"Beck LA, Thaci D, Hamilton JD et al (2014) Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med 371:130\u2013139","journal-title":"N Engl J Med"},{"key":"420_CR5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1710-1492-10-7","volume":"10","author":"P Begin","year":"2014","unstructured":"Begin P, Dominguez T, Wilson SP et al (2014a) Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using omalizumab. Allergy Asthma Clin Immunol 10:7","journal-title":"Allergy Asthma Clin Immunol"},{"key":"420_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1710-1492-10-1","volume":"10","author":"P Begin","year":"2014","unstructured":"Begin P, Winterroth LC, Dominguez T et al (2014b) Safety and feasibility of oral immunotherapy to multiple allergens for food allergy. Allergy Asthma Clin Immunol 10:1","journal-title":"Allergy Asthma Clin Immunol"},{"key":"420_CR7","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jaci.2009.02.004","volume":"123","author":"M Ben-Shoshan","year":"2009","unstructured":"Ben-Shoshan M, Kagan RS, Alizadehfar R et al (2009) Is the prevalence of peanut allergy increasing? A 5-year follow-up study in children in Montreal. J Allergy Clin Immunol 123:783\u2013788","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1081-1206(10)62175-8","volume":"91","author":"W Berger","year":"2003","unstructured":"Berger W, Gupta N, McAlary M et al (2003) Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma. Ann Allergy Asthma Immunol 91:182\u2013188","journal-title":"Ann Allergy Asthma Immunol"},{"key":"420_CR9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/ACI.0b013e32831952c8","volume":"8","author":"K Beyer","year":"2008","unstructured":"Beyer K, Wahn U (2008) Oral immunotherapy for food allergy in children. Curr Opin Allergy Clin Immunol 8:553\u2013556","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"420_CR10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jaci.2010.04.030","volume":"126","author":"K Blumchen","year":"2010","unstructured":"Blumchen K, Ulbricht H, Staden U et al (2010) Oral peanut immunotherapy in children with peanut anaphylaxis. J Allergy Clin Immunol 126:83\u201391.e1","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1067\/mai.2001.112031","volume":"107","author":"SA Bock","year":"2001","unstructured":"Bock SA, Munoz-Furlong A, Sampson HA (2001) Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 107:191\u2013193","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR12","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1378\/chest.125.4.1378","volume":"125","author":"J Bousquet","year":"2004","unstructured":"Bousquet J, Wenzel S, Holgate S et al (2004) Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma. Chest 125:1378\u20131386","journal-title":"Chest"},{"key":"420_CR13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaci.2010.10.008","volume":"126","author":"JA Boyce","year":"2010","unstructured":"Boyce JA, Assa\u2019ad A, Burks AW et al (2010) Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. J Allergy Clin Immunol 126:105\u20131118","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jaci.2006.09.016","volume":"119","author":"AD Buchanan","year":"2007","unstructured":"Buchanan AD, Green TD, Jones SM et al (2007) Egg oral immunotherapy in nonanaphylactic children with egg allergy. J Allergy Clin Immunol 119:199\u2013205","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1200435","volume":"367","author":"AW Burks","year":"2012","unstructured":"Burks AW, Jones SM, Wood RA et al (2012) Oral immunotherapy for treatment of egg allergy in children. N Engl J Med 367:233\u2013243","journal-title":"N Engl J Med"},{"key":"420_CR16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.immuni.2014.05.017","volume":"41","author":"OT Burton","year":"2014","unstructured":"Burton OT, Noval Rivas M, Zhou JS et al (2014) Immunoglobulin E signal inhibition during allergen ingestion leads to reversal of established food allergy and induction of regulatory T cells. Immunity 41:141\u2013151","journal-title":"Immunity"},{"key":"420_CR17","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1177\/039463201202500329","volume":"25","author":"S Carraro","year":"2012","unstructured":"Carraro S, Frigo AC, Perin M et al (2012) Impact of oral immunotherapy on quality of life in children with cow milk allergy: a pilot study. Int J Immunopathol Pharmacol 25:793\u2013798","journal-title":"Int J Immunopathol Pharmacol"},{"key":"420_CR18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/72601","volume":"18","author":"TW Chang","year":"2000","unstructured":"Chang TW (2000) The pharmacological basis of anti-IgE therapy. Nat Biotechnol 18:157\u2013162","journal-title":"Nat Biotechnol"},{"key":"420_CR19","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jaci.2006.04.005","volume":"117","author":"TW Chang","year":"2006","unstructured":"Chang TW, Shiung YY (2006) Anti-IgE as a mast cell-stabilizing therapeutic agent. J Allergy Clin Immunol 117:1203\u20131212 (quiz 1213)","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR20","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2217\/IMT.15.55","volume":"7","author":"KD Chhiba","year":"2015","unstructured":"Chhiba KD, Singh AM, Bryce PJ (2015) New developments in immunotherapies for food allergy. Immunotherapy 7:913\u2013922","journal-title":"Immunotherapy"},{"key":"420_CR21","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1398-9995.2009.01982.x","volume":"64","author":"AT Clark","year":"2009","unstructured":"Clark AT, Islam S, King Y et al (2009) Successful oral tolerance induction in severe peanut allergy. Allergy 64:1218\u20131220","journal-title":"Allergy"},{"key":"420_CR22","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2222.2009.03214.x","volume":"39","author":"J Corren","year":"2009","unstructured":"Corren J, Casale TB, Lanier B et al (2009) Safety and tolerability of omalizumab. Clin Exp Allergy 39:788\u2013797","journal-title":"Clin Exp Allergy"},{"key":"420_CR23","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jaci.2007.09.032","volume":"120","author":"L Cox","year":"2007","unstructured":"Cox L, Platts-Mills TA, Finegold I et al (2007) American Academy of Allergy, Asthma and Immunology\/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxis. J Allergy Clin Immunol 120:1373\u20131377","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jaci.2011.04.010","volume":"128","author":"L Cox","year":"2011","unstructured":"Cox L, Lieberman P, Wallace D et al (2011) American Academy of Allergy, Asthma and Immunology\/American College of Allergy, Asthma and Immunology Omalizumab-Associated Anaphylaxis Joint Task Force follow-up report. J Allergy Clin Immunol 128:210\u2013212","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1398-9995.2010.02342.x","volume":"65","author":"AJ Cummings","year":"2010","unstructured":"Cummings AJ, Knibb RC, King RM et al (2010) The psychosocial impact of food allergy and food hypersensitivity in children, adolescents and their families: a review. Allergy 65:933\u2013945","journal-title":"Allergy"},{"key":"420_CR26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1034\/j.1398-9995.2001.056005403.x","volume":"56","author":"M Eggesbo","year":"2001","unstructured":"Eggesbo M, Botten G, Halvorsen R et al (2001) The prevalence of allergy to egg: a population-based study in young children. Allergy 56:403\u2013411","journal-title":"Allergy"},{"issue":"348\u2013352","key":"420_CR27","first-page":"e2","volume":"109","author":"JM Factor","year":"2012","unstructured":"Factor JM, Mendelson L, Lee J et al (2012) Effect of oral immunotherapy to peanut on food-specific quality of life. Ann Allergy Asthma Immunol 109(348\u2013352):e2","journal-title":"Ann Allergy Asthma Immunol"},{"key":"420_CR28","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1365-2222.2004.01976.x","volume":"34","author":"MC Garcia-Ara","year":"2004","unstructured":"Garcia-Ara MC, Boyano-Martinez MT, Diaz-Pena JM et al (2004) Cow\u2019s milk-specific immunoglobulin E levels as predictors of clinical reactivity in the follow-up of the cow\u2019s milk allergy infants. Clin Exp Allergy 34:866\u2013870","journal-title":"Clin Exp Allergy"},{"key":"420_CR29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000321824","volume":"154","author":"Y Gernez","year":"2011","unstructured":"Gernez Y, Tirouvanziam R, Yu G et al (2011) Basophil CD203c levels are increased at baseline and can be used to monitor omalizumab treatment in subjects with nut allergy. Int Arch Allergy Immunol 154:318\u2013327","journal-title":"Int Arch Allergy Immunol"},{"key":"420_CR30","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1542\/peds.2011-0204","volume":"128","author":"RS Gupta","year":"2011","unstructured":"Gupta RS, Springston EE, Warrier MR et al (2011) The prevalence, severity, and distribution of childhood food allergy in the United States. Pediatrics 128:e9\u201317","journal-title":"Pediatrics"},{"key":"420_CR31","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/jamapediatrics.2013.2376","volume":"167","author":"R Gupta","year":"2013","unstructured":"Gupta R, Holdford D, Bilaver L et al (2013) The economic impact of childhood food allergy in the United States. JAMA Pediatr 167:1026\u20131031","journal-title":"JAMA Pediatr"},{"key":"420_CR32","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jaci.2014.10.013","volume":"134","author":"JD Hamilton","year":"2014","unstructured":"Hamilton JD, Suarez-Farinas M, Dhingra N et al (2014) Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis. J Allergy Clin Immunol 134:1293\u20131300","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jaci.2009.03.045","volume":"124","author":"AM Hofmann","year":"2009","unstructured":"Hofmann AM, Scurlock AM, Jones SM et al (2009) Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 124:286\u2013291, e1\u20136","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR34","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2222.2005.02191.x","volume":"35","author":"ST Holgate","year":"2005","unstructured":"Holgate ST, Djukanovic R, Casale T et al (2005) Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy. Clin Exp Allergy 35:408\u2013416","journal-title":"Clin Exp Allergy"},{"key":"420_CR35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1710-1492-10-36","volume":"10","author":"A Jagdis","year":"2014","unstructured":"Jagdis A, Berlin N, Barron C et al (2014) Effect of ketotifen premedication on adverse reactions during peanut oral immunotherapy. Allergy Asthma Clin Immunol 10:36","journal-title":"Allergy Asthma Clin Immunol"},{"key":"420_CR36","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jaci.2009.05.022","volume":"124","author":"SM Jones","year":"2009","unstructured":"Jones SM, Pons L, Roberts JL et al (2009) Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 124:292\u2013300, 300.e1\u201397","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR37","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/pai.12259","volume":"25","author":"I Lafuente","year":"2014","unstructured":"Lafuente I, Mazon A, Nieto M et al (2014) Possible recurrence of symptoms after discontinuation of omalizumab in anti-IgE-assisted desensitization to egg. Pediatr Allergy Immunol 25:717\u2013719","journal-title":"Pediatr Allergy Immunol"},{"key":"420_CR38","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.pcl.2015.07.015","volume":"62","author":"BJ Lanser","year":"2015","unstructured":"Lanser BJ, Wright BL, Orgel KA et al (2015) Current options for the treatment of food allergy. Pediatr Clin N Am 62:1531\u20131549","journal-title":"Pediatr Clin N Am"},{"key":"420_CR39","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJMoa022613","volume":"348","author":"DY Leung","year":"2003","unstructured":"Leung DY, Sampson HA, Yunginger JW et al (2003) Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 348:86\u2013993","journal-title":"N Engl J Med"},{"key":"420_CR40","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jaci.2007.10.029","volume":"121","author":"G Longo","year":"2008","unstructured":"Longo G, Barbi E, Berti I et al (2008) Specific oral tolerance induction in children with very severe cow\u2019s milk-induced reactions. J Allergy Clin Immunol 121:343\u2013347","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR41","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jaci.2013.07.018","volume":"132","author":"EC McGowan","year":"2013","unstructured":"McGowan EC, Keet CA (2013) Prevalence of self-reported food allergy in the National Health and Nutrition Examination Survey (NHANES) 2007\u2013\u20132010. J Allergy Clin Immunol 132:1216\u20131219.e5","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR42","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1517\/14712598.2015.1076388","volume":"15","author":"S McGregor","year":"2015","unstructured":"McGregor S, Farhangian ME, Feldman SR (2015) Dupilumab for the treatment of atopic dermatitis: a clinical trial review. Expert Opin Biol Ther 15:1657\u20131660","journal-title":"Expert Opin Biol Ther"},{"key":"420_CR43","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1111\/j.1398-9995.2004.00542.x","volume":"59","author":"P Meglio","year":"2004","unstructured":"Meglio P, Bartone E, Plantamura M et al (2004) A protocol for oral desensitization in children with IgE-mediated cow\u2019s milk allergy. Allergy 59:980\u2013987","journal-title":"Allergy"},{"key":"420_CR44","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jaci.2011.04.009","volume":"127","author":"KC Nadeau","year":"2011","unstructured":"Nadeau KC, Schneider LC, Hoyte L et al (2011) Rapid oral desensitization in combination with omalizumab therapy in patients with cow\u2019s milk allergy.\u201d. J Allergy Clin Immunol 127:1622\u20131624","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1710-1492-10-25","volume":"10","author":"IM Otani","year":"2014","unstructured":"Otani IM, Begin P, Kearney C et al (2014) Multiple-allergen oral immunotherapy improves quality of life in caregivers of food-allergic pediatric subjects. Allergy Asthma Clin Immunol 10:25","journal-title":"Allergy Asthma Clin Immunol"},{"key":"420_CR46","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1046\/j.1365-2036.2003.01468.x","volume":"17","author":"G Patriarca","year":"2003","unstructured":"Patriarca G, Nucera E, Roncallo C et al (2003) Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment Pharmacol Ther 17:459\u2013465","journal-title":"Aliment Pharmacol Ther"},{"key":"420_CR47","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1586\/1744666X.2015.1010517","volume":"11","author":"B Pauwels","year":"2015","unstructured":"Pauwels B, Jonstam K, Bachert C (2015) Emerging biologics for the treatment of chronic rhinosinusitis. Expert Rev Clin Immunol 11:349\u2013361","journal-title":"Expert Rev Clin Immunol"},{"key":"420_CR48","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/apa.13044","volume":"104","author":"JL Protudjer","year":"2015","unstructured":"Protudjer JL, Jansson SA, Ostblom E et al (2015) Health-related quality of life in children with objectively diagnosed staple food allergy assessed with a disease-specific questionnaire. Acta Paediatr 104:1047\u20131054","journal-title":"Acta Paediatr"},{"issue":"1309\u20131310","key":"420_CR49","first-page":"e1","volume":"127","author":"HA Sampson","year":"2011","unstructured":"Sampson HA, Leung DY, Burks AW et al (2011) A phase II, randomized, doubleblind, parallelgroup, placebocontrolled oral food challenge trial of Xolair (omalizumab) in peanut allergy. J Allergy Clin Immunol 127(1309\u20131310):e1","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000361025","volume":"164","author":"S Sato","year":"2014","unstructured":"Sato S, Yanagida N, Ogura K et al (2014) Clinical studies in oral allergen-specific immunotherapy: differences among allergens. Int Arch Allergy Immunol 164:1\u20139","journal-title":"Int Arch Allergy Immunol"},{"issue":"1123\u20131129","key":"420_CR51","first-page":"e2","volume":"130","author":"JH Savage","year":"2012","unstructured":"Savage JH, Courneya JP, Sterba PM et al (2012) Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy. J Allergy Clin Immunol 130(1123\u20131129):e2","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR52","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jaci.2013.09.046","volume":"132","author":"LC Schneider","year":"2013","unstructured":"Schneider LC, Rachid R, LeBovidge J et al (2013) A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients. J Allergy Clin Immunol 132:1368\u20131374","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR53","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/WOX.0b013e318187a310","volume":"1","author":"M Segal","year":"2008","unstructured":"Segal M, Stokes JR, Casale TB (2008) Anti-immunoglobulin e therapy. World Allergy Organ J 1:174\u2013183","journal-title":"World Allergy Organ J"},{"key":"420_CR54","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jaci.2004.04.032","volume":"114","author":"LP Shek","year":"2004","unstructured":"Shek LP, Soderstrom L, Ahlstedt S et al (2004) Determination of food specific IgE levels over time can predict the development of tolerance in cow\u2019s milk and hen\u2019s egg allergy. J Allergy Clin Immunol 114:387\u2013391","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR55","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jaci.2010.11.044","volume":"127","author":"SH Sicherer","year":"2011","unstructured":"Sicherer SH (2011) Epidemiology of food allergy. J Allergy Clin Immunol 127:594\u2013602","journal-title":"J Allergy Clin Immunol"},{"issue":"2 Suppl 2","key":"420_CR56","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.jaci.2009.08.028","volume":"125","author":"SH Sicherer","year":"2010","unstructured":"Sicherer SH, Sampson HA (2010) Food allergy. J Allergy Clin Immunol 125(2 Suppl 2):S116\u2013S125","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR57","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1081-1206(10)62258-2","volume":"87","author":"SH Sicherer","year":"2001","unstructured":"Sicherer SH, Noone SA, Munoz-Furlong A (2001) The impact of childhood food allergy on quality of life. Ann Allergy Asthma Immunol 87:461\u2013464","journal-title":"Ann Allergy Asthma Immunol"},{"key":"420_CR58","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0091-6749(03)02026-8","volume":"112","author":"SH Sicherer","year":"2003","unstructured":"Sicherer SH, Munoz-Furlong A, Sampson HA (2003) Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study. J Allergy Clin Immunol 112:1203\u20131207","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR59","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1067\/mai.2001.112129","volume":"107","author":"HS Skolnick","year":"2001","unstructured":"Skolnick HS, Conover-Walker MK, Koerner CB et al (2001) The natural history of peanut allergy. J Allergy Clin Immunol 107:367\u2013374","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR60","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jaci.2008.09.030","volume":"122","author":"JM Skripak","year":"2008","unstructured":"Skripak JM, Nash SD, Rowley H et al (2008) A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow\u2019s milk allergy. J Allergy Clin Immunol 122:1154\u20131160","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR61","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jaci.2012.06.029","volume":"130","author":"L Soller","year":"2012","unstructured":"Soller L, Ben-Shoshan M, Harrington DW et al (2012) Overall prevalence of self-reported food allergy in Canada. J Allergy Clin Immunol 130:986\u2013988","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR62","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/0884533613505870","volume":"28","author":"C Sova","year":"2013","unstructured":"Sova C, Feuling MB, Baumler M et al (2013) Systematic review of nutrient intake and growth in children with multiple IgE-mediated food allergies. Nutr Clin Pract 28:669\u2013675","journal-title":"Nutr Clin Pract"},{"key":"420_CR63","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1398-9995.2007.01501.x","volume":"62","author":"U Staden","year":"2007","unstructured":"Staden U, Rolinck-Werninghaus C, Brewe F et al (2007) Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy 62:1261\u20131269","journal-title":"Allergy"},{"key":"420_CR64","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaci.2008.06.002","volume":"122","author":"U Staden","year":"2008","unstructured":"Staden U, Blumchen K, Blankenstein N et al (2008) Rush oral immunotherapy in children with persistent cow\u2019s milk allergy. J Allergy Clin Immunol 122:418\u2013419","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR65","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1710-1492-10-3","volume":"10","author":"M Takahashi","year":"2014","unstructured":"Takahashi M, Taniuchi S, Soejima K et al (2014) New efficacy of LTRAs (montelukast sodium): it possibly prevents food-induced abdominal symptoms during oral immunotherapy. Allergy Asthma Clin Immunol 10:3","journal-title":"Allergy Asthma Clin Immunol"},{"key":"420_CR66","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13223-015-0084-y","volume":"11","author":"M Takahashi","year":"2015","unstructured":"Takahashi M, Taniuchi S, Soejima K et al (2015) Successful desensitization in a boy with severe cow\u2019s milk allergy by a combination therapy using omalizumab and rush oral immunotherapy. Allergy Asthma Clin Immunol 11:18","journal-title":"Allergy Asthma Clin Immunol"},{"key":"420_CR67","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40413-015-0070-3","volume":"8","author":"DT Umetsu","year":"2015","unstructured":"Umetsu DT, Rachid R, Schneider LC (2015) Oral immunotherapy and anti-IgE antibody treatment for food allergy. World Allergy Organ J 8:20","journal-title":"World Allergy Organ J"},{"key":"420_CR68","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaci.2010.12.1111","volume":"127","author":"P Varshney","year":"2011","unstructured":"Varshney P, Jones SM, Scurlock AM et al (2011) A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 127:654\u2013660","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR69","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/all.12072","volume":"68","author":"K Wakahara","year":"2013","unstructured":"Wakahara K, Van VQ, Baba N et al (2013) Basophils are recruited to inflamed lungs and exacerbate memory Th2 responses in mice and humans. Allergy 68:180\u2013189","journal-title":"Allergy"},{"key":"420_CR70","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","volume":"368","author":"S Wenzel","year":"2013","unstructured":"Wenzel S, Ford L, Pearlman D et al (2013) Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 368:2455\u20132466","journal-title":"N Engl J Med"},{"issue":"1103\u20131110","key":"420_CR71","first-page":"e11","volume":"137","author":"RA Wood","year":"2016","unstructured":"Wood RA, Kim JS, Lindblad R et al (2016) A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow\u2019s milk allergy. J Allergy Clin Immunol 137(1103\u20131110):e11","journal-title":"J Allergy Clin Immunol"},{"key":"420_CR72","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1038\/srep11581","volume":"5","author":"JD Wright","year":"2015","unstructured":"Wright JD, Chu HM, Huang CH et al (2015) Structural and physical basis for anti-IgE therapy. Sci Rep 5:11581","journal-title":"Sci Rep"},{"key":"420_CR73","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaci.2006.04.024","volume":"118","author":"JW Yu","year":"2006","unstructured":"Yu JW, Kagan R, Verreault N et al (2006) Accidental ingestions in children with peanut allergy. J Allergy Clin Immunol 118:466\u2013472","journal-title":"J Allergy Clin Immunol"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-016-0420-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-016-0420-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-016-0420-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:48:51Z","timestamp":1704228531000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-016-0420-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,14]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["420"],"URL":"https:\/\/doi.org\/10.1007\/s00005-016-0420-z","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,14]]}}}